These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 27819760)
1. Reversible cerebral vasoconstriction syndrome in association with fingolimod use. Belliston S; Sundararajan J; Hammond N; Newell K; Lynch S Int J Neurosci; 2017 Sep; 127(9):831-834. PubMed ID: 27819760 [TBL] [Abstract][Full Text] [Related]
2. Reversible cerebral vasoconstriction syndrome associated with fingolimod treatment in relapsing-remitting multiple sclerosis three months after childbirth. Kraemer M; Weber R; Herold M; Berlit P Mult Scler; 2015 Oct; 21(11):1473-5. PubMed ID: 26283695 [TBL] [Abstract][Full Text] [Related]
8. A Case of Reversible Cerebral Vasoconstriction Syndrome Triggered by High-Dose Methotrexate in a Boy With Lymphoma. Wang X; Zhang Y; You H; Zhu T; Zhou D Headache; 2020 Sep; 60(8):1767-1772. PubMed ID: 30985924 [TBL] [Abstract][Full Text] [Related]
19. Diffuse cerebrovascular dilation: Case report of amezinium metilsulfate-induced reversible cerebral vasoconstriction syndrome. Kobayashi M Cephalalgia; 2016 Mar; 36(3):289-93. PubMed ID: 26016487 [TBL] [Abstract][Full Text] [Related]
20. A common cause of sudden and thunderclap headaches: reversible cerebral vasoconstriction syndrome. Cheng YC; Kuo KH; Lai TH J Headache Pain; 2014 Mar; 15(1):13. PubMed ID: 24580731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]